IRIS PubliCatt

Rapaccini, Gian Ludovico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.488
NA - Nord America 5.765
AS - Asia 2.114
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 20
SA - Sud America 20
OC - Oceania 15
Totale 14.466
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.712
DE - Germania 2.500
SE - Svezia 1.314
CN - Cina 930
SG - Singapore 608
IT - Italia 572
UA - Ucraina 568
IE - Irlanda 417
FR - Francia 288
GB - Regno Unito 232
ID - Indonesia 226
FI - Finlandia 197
RU - Federazione Russa 145
TR - Turchia 115
IN - India 114
PL - Polonia 65
BE - Belgio 55
CA - Canada 35
CI - Costa d'Avorio 35
JP - Giappone 31
CZ - Repubblica Ceca 22
HK - Hong Kong 19
CH - Svizzera 18
IR - Iran 18
NL - Olanda 18
EU - Europa 16
VN - Vietnam 14
BZ - Belize 13
RO - Romania 13
LT - Lituania 12
AU - Australia 11
TW - Taiwan 11
BR - Brasile 10
AT - Austria 7
ES - Italia 7
GR - Grecia 7
PT - Portogallo 7
CL - Cile 6
DK - Danimarca 5
HU - Ungheria 5
KR - Corea 5
NZ - Nuova Zelanda 4
KZ - Kazakistan 3
MX - Messico 3
SC - Seychelles 3
A1 - Anonimo 2
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BY - Bielorussia 2
EE - Estonia 2
IL - Israele 2
LK - Sri Lanka 2
MK - Macedonia 2
NO - Norvegia 2
PA - Panama 2
PH - Filippine 2
RE - Reunion 2
SD - Sudan 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AZ - Azerbaigian 1
EC - Ecuador 1
EG - Egitto 1
IQ - Iraq 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MM - Myanmar 1
MY - Malesia 1
PE - Perù 1
PY - Paraguay 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 14.466
Salva come PNG Salva come JPEG
Città #
Chandler 1.208
Singapore 493
Ashburn 448
Dublin 416
Jacksonville 320
New York 258
San Mateo 250
Nanjing 230
Jakarta 226
Ann Arbor 163
Nürnberg 162
Wilmington 156
Boston 142
Dearborn 139
Houston 128
Princeton 125
Moscow 110
Milan 103
Izmir 102
Chicago 99
Marseille 99
Cattolica 87
Los Angeles 85
Helsinki 84
Beijing 82
Munich 79
Woodbridge 79
Nanchang 69
Rome 63
Bremen 61
Redwood City 61
Redmond 60
Seattle 59
Brussels 53
Fairfield 52
Kraków 52
Boardman 47
Shenyang 46
San Jose 42
Lawrence 41
Hebei 38
Lancaster 36
Abidjan 35
Mountain View 34
Norwalk 33
Tianjin 33
Zhengzhou 32
Kunming 30
University Park 29
Hangzhou 28
Pune 27
Changsha 26
Leawood 24
Augusta 23
Bologna 23
Jiaxing 22
Guangzhou 21
Jinan 20
Falls Church 19
Shanghai 19
Detroit 18
London 18
Edinburgh 17
Las Vegas 17
Brno 16
Hong Kong 16
Toronto 16
Paris 15
Buffalo 14
Castelnuovo di Val di Cecina 14
Belize City 13
Hanoi 13
Washington 13
Fremont 12
Hefei 12
Lanzhou 12
Warsaw 12
Andover 11
Cambridge 10
Ottawa 10
Tokyo 10
Zurich 10
Atlanta 9
Costa Mesa 9
Frankfurt am Main 9
Kish 9
San Diego 9
Simi Valley 9
Taipei 9
Auburn Hills 8
Changchun 8
Phoenix 8
Portland 8
Boydton 7
Cagliari 7
Sacramento 7
Taizhou 7
Albuquerque 6
Bern 6
Busto Arsizio 6
Totale 7.571
Salva come PNG Salva come JPEG
Nome #
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging 392
Association between Klinefelter syndrome and focal nodular hyperplasia 261
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 211
gc) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. 185
Long term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma <= 3 cm. Results of a multicenter Italian survey. 183
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 181
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 181
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 160
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 157
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 152
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 147
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 145
Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients. 144
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 144
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study 144
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study 139
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 139
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants. 135
Infliximab in Steroid-dependent Ulcerative Colitis: Effectiveness and Predictors of Clinical and Endoscopic Remission. 135
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 131
Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis. 130
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 128
recurrent acute hepatitis associated with use of cetrizine 126
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 126
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 124
A case of non-occlusive mesenteric ischemia and hepatic portal venous gas: not everyone knows that… 123
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 122
Potential use of liver function breath tests in the clinical practice. 120
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 116
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 113
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 108
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year. 101
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 100
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection 99
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 99
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 99
Evaluation of the albumin-gamma-glutamyl transferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis. 99
Magnesium Absorption in Intestinal Cells: Evidence of Cross-Talk between EGF and TRPM6 and Novel Implications for Cetuximab Therapy 98
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 96
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 94
Severe Skin Burn at Needle Entry Point Complicating Radiofrequency Ablation for Hepatocellular Carcinoma 92
DNA ploidy pattern in human chronic liver diseases and hepatic nodular lesions. Flow cytometric analysis on echo-guided needle liver biopsy 92
Liver transplantation in patients with alcoholic liver disease: A retrospective study 92
Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma 91
Doppler ultrasonographic evaluation of blood flow in the superior mesenteric artery in celiac patients and in healthy controls in fasting conditions and after saccharose ingestion 91
[Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients] 89
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing. 89
Lipohyperplasia of the ileocaecal valve as a cause of intestinal haemorrhage: an ultrasound Doppler study 88
Gastric wall thickness in normal and neoplastic subjects: a prospective study performed by abdominal ultrasound 88
Single Hepatocellular Carcinoma Smaller than 2 cm: Are Ethanol Injection and Radiofrequency Ablation Equally Effective? 88
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study 87
Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases 87
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 86
[Liver transplantation] 85
Immunological role of IgG subclasses 83
Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. 82
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 82
Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. 80
Amantadine-induced livedo reticularis occurring during treatment of chronic hepatitis C 79
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 79
Liver transplantation in Italy: preliminary 10-year report. The Monotematica Aisf-Olt Study Group 78
Contrast-enhanced power doppler of the intestinal wall in the evaluation of patients with Crohn disease 78
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 78
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 78
Botulinum toxin-B ultrasound-guided injections for sialorrhea in amytrophic lateral sclerosis and Parkinson's disease 77
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 77
Is coeliac disease a confounding factor in the diagnosis of NASH? 76
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 76
Sarilumab use in severe SARS-CoV-2 pneumonia 76
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 74
Clinical suspicion of pancreatic neoplasm: does echo-guided fine-needle biopsy modify patient management? 73
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 73
Gallbladder emptying, plasma levels of estradiol and progesterone, and cholecystokinin secretion in liver cirrhosis 72
Impairment of recent thymic emigrants in HCV infection. 71
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing 71
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 71
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules 70
Acute hepatitis associated with use of paroxetine 69
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome 68
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 68
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 68
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma 68
Bridge treatments of hepatocellular carcinoma in cirrhotic patients submitted to liver transplantation 67
Neoplastic seeding complicating percutaneous ethanol injection for treatment of hepatocellular carcinoma 67
Contrast-enhanced ultrasonography in chronic glomerulonephritides: correlation with histological parameters of disease activity 67
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 67
Development and validation of predictive assessment of complicated diverticulitis score 67
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 66
Cruveilhier-Baumgarten syndrome: an efficient spontaneous portosystemic collateral preventing oesophageal varices bleeding 65
Long-term effectiveness of Radiofrequency Ablation for solitary small Hepatocellular Carcinoma: A retrospective analysis of 363 patients 65
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma 65
The Laboratory Role in anti-TNF Biological Therapy Era 65
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 65
Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation 64
Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk 64
Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19 64
Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy 63
Primary neoplasm of the duodenum diagnosed by echo-guided fine-needle biopsy 63
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 63
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 63
Totale 10.197
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.096
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.096
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.071 0 0 0 0 144 207 150 82 103 109 139 137
2020/20211.225 67 114 46 141 149 41 115 28 168 58 260 38
2021/20221.642 110 118 39 140 102 54 34 221 66 107 283 368
2022/20233.736 476 436 268 501 296 434 227 314 446 97 163 78
2023/20242.071 115 556 64 135 82 355 113 88 26 125 160 252
2024/20251.029 108 107 379 117 318 0 0 0 0 0 0 0
Totale 14.732